Percutaneous coronary intervention for unprotected left main coronary artery stenosis

Seung-Jung Park1, Young-Hak Kim

  • 1Seung-Jung Park, Young-Hak Kim, Cardiac Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul 138-736, South Korea.

World Journal of Cardiology
|December 17, 2010
PubMed

Insights

Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) offers acceptable outcomes for unprotected left main coronary artery stenosis (LMCA). Further studies are needed to compare PCI with DES against coronary artery bypass graft (CABG) surgery.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology

Background:

  • Hemodynamically significant left main coronary artery stenosis (LMCA) affects approximately 4% of diagnostic coronary angiograms.
  • Unprotected LMCA stenosis occurs when there are no patent grafts to the left coronary artery or left circumflex artery.
  • Historically, coronary artery bypass graft (CABG) surgery has shown reduced mortality compared to medical treatment for LMCA stenosis.

Purpose of the Study:

  • To evaluate the long-term outcomes of percutaneous coronary intervention (PCI) using drug-eluting stents (DES) for unprotected LMCA stenosis.
  • To inform clinical decision-making for patients unsuitable for or refusing CABG surgery.
  • To highlight the need for future randomized trials comparing PCI with DES versus CABG for unprotected LMCA stenosis.

Main Methods:

  • Review of previous randomized studies on revascularization for LMCA stenosis.
  • Analysis of outcomes associated with PCI using DES in unprotected LMCA stenosis.
  • Consideration of patient risk factors and treatment preferences.

Main Results:

  • Current guidelines recommend CABG over PCI for unprotected LMCA stenosis due to proven surgical benefits and historical high restenosis rates with bare metal stents.
  • The advent of DES has led to acceptable long-term outcomes for PCI in treating unprotected LMCA stenosis.
  • PCI with DES is increasingly utilized for high-risk patients or those who refuse CABG.

Conclusions:

  • PCI with DES presents a viable alternative for unprotected LMCA stenosis, particularly in specific patient populations.
  • Further randomized controlled trials are essential to directly compare the efficacy of PCI with DES versus CABG for unprotected LMCA stenosis.
  • Such studies will advance clinical knowledge and guide the optimal treatment strategy for this critical condition.

Related Concept Videos

Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...